Stockholder Alert: Robbins LLP Informs Marex Group PLC Stockholders that a Class Action Lawsuit was Filed Against the Company

SunTx Capital Partners’ Portfolio Company, Suncrete, to Pursue Listing on the New York Stock Exchange through a Proposed Business Combination with Haymaker Acquisition Corp. 4

Forbidden gates swing open

“Answer the Call”: vivo at 30, Still Listening, Still Building

Biopharma-Führungskräfte bringen die Zukunft der Biowissenschaften auf dem Veeva Commercial Summit Europe voran

Lockheed Martin Declares Fourth Quarter 2025 Dividend

WasabiCon – Jacksonville, Florida’s Largest Pop Culture Event

Vinitaly.USA 2025 Wraps Up in Chicago With Strong Momentum for Italian Wine

St. Matthew’s Parish School Unveils Comprehensive Plans for Return to Pacific Palisades Campus in Fall 2026

VFC SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of V.F. Corporation

Franklin County Bell Across PA Is On The Move Throughout Franklin County

CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

LFMD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)

SMLR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific

RE/MAX HOLDINGS, INC. TO RELEASE THIRD QUARTER 2025 RESULTS ON OCTOBER 30, 2025

Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval

Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer’s Disease Research

Grace Adventures Ministries Announces President Retirement

Aetna achieves over 81% of Medicare Advantage members in 4-Star plans and over 63% in 4.5-Star plans for 2026